Menu Search
Equities

CirChem AB

CRB:DUS

CirChem AB

Actions
  • Price (EUR)0.213
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change-8.58%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024 15:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in SEKIncome statement in SEKView more

Year on year CirChem AB grew revenues 872.63% from 590.62k to 5.74m while net income improved from a loss of 22.72m to a smaller loss of 17.14m.
Gross margin12.43%
Net profit margin-142.61%
Operating margin-130.29%
Return on assets-20.38%
Return on equity-31.44%
Return on investment-28.28%
More ▼

Cash flow in SEKView more

In 2023, CirChem AB increased its cash reserves by 69.61%, or 6.81m. Cash Flow from Financing totalled 34.29m or 596.84% of revenues. In addition the company used 26.68m for operations while cash used for investing totalled 798.49k.
Cash flow per share-0.4037
Price/Cash flow per share--
Book value per share1.09
Tangible book value per share1.09
More ▼

Balance sheet in SEKView more

CirChem AB has a Debt to Total Capital ratio of 17.34%, a higher figure than the previous year's 2.94%.
Current ratio0.8918
Quick ratio0.8756
Total debt/total equity0.2098
Total debt/total capital0.1734
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.